Efineptakin alfa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Efineptakin alfa, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma [Phase 2]